Epi Biotech Co (XKRX:446440) Change In Receivables : ₩0.00 Mil (TTM As of . 20)

View and export this data going back to 2023. Start your Free Trial

What is Epi Biotech Co Change In Receivables?

Epi Biotech Co's change in receivables for the quarter that ended in . 20 was ₩0.00 Mil. It means Epi Biotech Co's Accounts Receivable stayed the same from . 20 to . 20 .

Epi Biotech Co's change in receivables for the fiscal year that ended in . 20 was ₩0.00 Mil. It means Epi Biotech Co's Accounts Receivable stayed the same from . 20 to . 20 .

Epi Biotech Co's Accounts Receivable for the quarter that ended in . 20 was ₩0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Epi Biotech Co's liquidation value for the six months ended in . 20 was ₩0.00 Mil.

Epi Biotech Co Change In Receivables Historical Data

The historical data trend for Epi Biotech Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Epi Biotech Co Change In Receivables Chart

Epi Biotech Co Annual Data

Trend

Change In Receivables

Epi Biotech Co Semi-Annual Data

Change In Receivables

Epi Biotech Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Change In Receivables for the trailing twelve months (TTM) ended in . 20 was ₩0.00 Mil.

Epi Biotech Co (XKRX:446440) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Epi Biotech Co's Days Sales Outstanding for the quarter that ended in . 20 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=		/		*	91
=

2. In Ben Graham's calculation of liquidation value, Epi Biotech Co's accounts receivable are only considered to be worth 75% of book value:

Epi Biotech Co's liquidation value for the quarter that ended in . 20 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=		-		+	0.75 *	+	0.5 *
=	0.00

Epi Biotech Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Epi Biotech Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Epi Biotech Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Epi Biotech Co Ltd (XKRX:446440) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

32, Songdogwahak-ro, Rooms 1903 and 1904, 15th floor, M-dong, Yeonsu-gu, Incheon, KOR, 21984

Website

http://www.epibiotech.com

Epi Biotech Co Ltd is developing various pipelines for each hair loss treatment modality. It also conducts R&D in skin regeneration treatments to create commercially viable consumer products. The company specializes in hair loss treatment in Korea.

Epi Biotech Co Headlines

No Headlines